Skip to main content
. 2021 Feb 8;25(5):1129–1135. doi: 10.1007/s10029-021-02372-1

Table 4.

Influence of multimorbidity

Multimorbidity p-value
No (n = 361) Yes (n = 555)
Gender
 Male 333 (92.2%) 498 (89.7%) 0.244
 Female 28 (7.8%) 57 (10.3%)
Age [years] 46.1 ± 16.3 60.1 ± 15.0  < 0.001
Hernia side
 Right 184 (51.0%) 295 (53.2%) 0.785
 Left 140 (38.8%) 203 (36.6%)
 Bilateral 37 (10.2%) 57 (10.3%)
Recurrent Hernia [yes] 48 (13.3%) 70 (12.6%) 0.783
Emergency/incarceration [yes] 6 (1.7%) 38 (6.8%)  < 0.001
PCCL
 0 357 (98.9%) 331 (59.6%)  < 0.001
 1 2 (0.6%) 53 (9.5%)
 2 1 (0.3%) 56 (10.1%)
 3 73 (13.2%)
 4 37 (6.7%)
 5 5 (0.9%)
Operative procedure
 Open Mesh (Lichtenstein) 121 (33.5%) 262 (47.2%)  < 0.001
 Open Suture (Shouldice) 5 (1.4%) 3 (0.5%)
 Laparoscopic (TAPP) 235 (65.1%) 290 (52.3%)
Operative time [minutes] 86.8 ± 31.6 95.6 ± 40.7 0.001
Postoperative Complications [yes]
 Overall 4 (1.1%) 34 (6.1%)  < 0.001
 Hematoma/bleeding 3 (0.8%) 17 (3.1%)
 Electrolyte disorders/dialysis 3 (0.5%)
 Wound healing disorders 2 (0.4%)
 Early recurrence 2 (0.4%)
 Paresthesia 2 (0.4%)
 Ileus 2 (0.4%)
 Other 1 (0.3%) 6 (1.1%)
Length of hospital stay [days] 1.9 ± 0.9 3.1 ± 2.8  < 0.001
Overall cost [€] 2898.1 ± 754.8 3624.7 ± 1921.5  < 0.001
Hospital reimbursement [€] 2473.3 ± 716.9 3087.0 ± 1772.5  < 0.001
Reimbursement—cost [€] − 404.4 ± 869.3 − 515.0 ± 1545.1 0.450

Values as numbers and percentage or in means ± standard deviation

TAPP transabdominal preperitoneal, PCCL patient clinical complexity level